A new report published by Swiss company IQAir found that only seven countries and three territories last year met World Health Organization pollution guidelines for fine particulate matter, the most risky form of pollution to human health. The report examined this pollution, known as PM 2.5, which is linked to multiple ailments: heart attacks, strokes, asthma attacks, and premature death, using over 30,000 monitoring stations in 134 countries. The U.S. was not among that set of seven countries; last month the EPA lowered the acceptable annual amount of PM 2.5 to reflect new findings on its dangers. Reacting to IQAir’s findings, Greenpeace International senior air quality scientist Aidan Farrow said, “In 2023, air pollution remained a global health catastrophe.”
According to the Washington Post report (March 20, 2024), “Of these countries, seven had annual averages within the WHO’s guidelines of 5 micrograms per cubic meter in 2023: Australia, Estonia, Finland, Grenada, Iceland, Mauritius and New Zealand. French Polynesia, Bermuda, and Puerto Rico also met the guidelines.”
Thomas Kluz is a distinguished healthcare futurist, skilled investment professional, and expert in biomedical sciences.
With a keen eye on the future of health care, Thomas has been at the forefront of identifying and fostering groundbreaking innovations that redefine the landscape of medical technology and patient care. His extensive experience in both the investment and biomedical sectors equips him with a unique perspective, enabling him to navigate and influence the rapidly evolving healthcare industry.
Thomas is known for his strategic vision, deep scientific knowledge, and unwavering commitment to advancing healthcare solutions that improve lives and drive sustainable growth.
The Eden Magazine was honored to speak with Thomas Kluz about his vision and personal thoughts on the healthcare industry.
What motivated you to pursue a career at the intersection of healthcare technology, investment, and biomedicine?
I wanted to make real changes in healthcare. I’ve always been fascinated by how technology can improve patient care. For example, seeing how telemedicine can connect patients in remote areas to doctors inspired me. As I went through school and work, this interest grew into a commitment to bring new ideas to healthcare. As a venture capitalist, I saw the chance to invest in startups that can make healthcare more efficient, affordable, and accessible, benefiting both investors and communities.
What are the most promising trends you see in healthcare technology over the next five to ten years?
Several big trends will shape healthcare in the next five to ten years. Telemedicine and remote patient monitoring will continue to make healthcare more accessible. For example, wearable devices like smartwatches as can track heart health and alert doctors to any problems. Many devices that were once large, such as physical devices, will be digitized. AI advancements will help with better diagnostics and personalized treatments. Generative AI, which creates new data from existing data, is already helping by generating synthetic medical records to train healthcare algorithms without risking patient privacy. Investing in these technologies can provide long-term value by improving patient outcomes and reducing healthcare costs.
How do you envision artificial intelligence transforming patient care and diagnostics in the near future?
AI can greatly improve patient care and diagnostics. For example, AI algorithms can analyze medical images, such as X-rays or MRIs, to detect diseases earlier and more accurately than humans. Generative AI can create realistic 3D models of organs for better surgical planning. AI can also help doctors make better decisions by analyzing large amounts of data to spot patterns and trends, leading to earlier disease detection and better treatment plans. These innovations can reduce the burden on healthcare systems and improve the quality of care, making them
attractive investments.
How do you see the role of wearable technology evolving in personal health management?
Wearable technology will become essential in managing personal health. Devices like fitness trackers and smartwatches can monitor vital signs and activity levels in real-time. For example, smartwatches can detect irregular heartbeats and prompt users to seek medical attention. As these devices get better and more affordable, they will help with preventive care and managing chronic diseases. Investing in wearable tech startups can provide long-term returns by promoting healthier lifestyles and reducing healthcare costs.
What key factors do you consider when deciding to invest in a healthcare startup?
When investing in healthcare startups, I look for a few key things. The most important is the uniqueness and potential impact of their technology. For instance, a startup developing a new AI-powered diagnostic tool that can detect cancer early would catch my interest. I also consider the strength of the team, scalability of the business model, regulatory environment, clinical proof of effectiveness, market interest, and a clear plan for commercialization. Investing in companies that can scale and meet regulatory standards ensures long-term growth and community impact.
Can you share a success story from your investment portfolio highlighting innovative healthcare technology?
One success story is a startup that developed a cutting-edge medical device for minimally invasive surgery. This device used advanced robotics and imaging technology to improve surgical precision and patient outcomes. For example, their robot-assisted surgery system allowed surgeons to perform complex procedures with more accuracy, reducing recovery times. Through strategic partnerships and marketing, the company successfully brought the product to market, transforming surgical practices and improving patient care globally. This investment not only generated strong financial returns but also positively impacted patients’ lives.
Which areas in biotechnology do you believe are ripe for breakthrough innovations?
Several areas in biotechnology have huge potential for breakthroughs, including gene therapy, regenerative medicine, immunotherapy, and microbiome research. For example, gene therapy can potentially cure genetic disorders like cystic fibrosis by fixing defective genes. Generative AI is also aiding in drug discovery by simulating how new drugs interact with the body, speeding up the development of new treatments. Investing in these areas can lead to significant medical advancements and substantial returns.
How do you see the scalability of future air purifying technology, from home units to large outdoor mega-filters, impacting public health and environmental sustainability?
Scalable air purifying technology can greatly impact public health and environmental sustainability. For example, home air purifiers can reduce indoor air pollution, improving health for people with asthma. Large outdoor air filters can clean the air in polluted cities, benefiting everyone’s health. Investing in these technologies can reduce pollution’s harmful effects, especially in crowded cities and industrial areas, providing long-term environmental and health benefits.
Can you elaborate on how advanced technologies, such as the development of ‘cold plasma’ for air purification and cooling, propel us into the future amidst the accelerating decline caused by climate change?
Cold plasma technology can help with both air purification and fighting climate change. It uses ionized gas to clean the air without chemicals and is energy-efficient. For example, cold plasma can be used in air purifiers to neutralize pollutants and pathogens in the air. By using cold plasma, we can reduce pollution, improve air quality, and lower our carbon footprint, helping to combat climate change. Investing in such technologies addresses not only environmental challenges but also offers strong growth potential as demand for clean air solutions rises.
Why is the use of ceramics ideal for air purification, particularly in terms of its ability to absorb surrounding moisture and maintain dryness?
Ceramics are great for air purification because they can absorb moisture and stay dry, preventing mold and bacteria growth. For example, air purifier ceramic filters can effectively capture pollutants, allergens, and odors. Ceramics are also durable and environmentally friendly, making them ideal for long-term use in air purification. Investing in companies that use ceramic technology for air purification can provide sustainable solutions for cleaner air.
What advice would you give to entrepreneurs looking to innovate in the healthcare technology space?
For entrepreneurs in healthcare technology, my advice is: First, find unmet needs and problems in healthcare and develop solutions for them. For example, a startup could focus on creating an app that helps manage diabetes more effectively. Second, focus on clinical validation and regulatory compliance early to speed up market entry. Third, build a diverse team with different skills and expertise. Lastly, form strategic partnerships with healthcare providers, payers, and industry stakeholders to help with product development, validation, and commercialization. This approach can ensure long-term success and community impact.
What is your vision for the future of healthcare, and what steps are you taking to make it a reality?
I envision a future where healthcare is accessible, affordable, and equitable. Technology will deliver personalized care, promote preventive medicine, and address social determinants of health. To achieve this, I am investing in innovative healthcare technologies, supporting startups that drive positive change, and advocating for policies that promote innovation and patient empowerment. For example, I support digital health initiatives that make it easier for people in remote areas to access healthcare. These steps aim to create a healthier society while providing long-term investment returns.
What are your thoughts on the current state of data interoperability in healthcare, and what improvements are needed?
Healthcare data interoperability currently needs to be more cohesive, with different systems and standards making it hard to share and integrate patient data. To improve this, we need common data standards, interoperable IT infrastructure, and secure data exchange protocols. For example, using standardized formats for electronic health records (EHRs) can make it easier to share information between different healthcare providers. We also need to address privacy and security concerns and give patients more control over their health information. Investing in interoperability solutions can streamline healthcare delivery and improve patient outcomes.
How should the healthcare industry address the growing concerns around cybersecurity and patient data protection?
The healthcare industry must proactively address cybersecurity and data protection concerns. This includes implementing strong cybersecurity protocols, conducting regular security audits, and investing in employee training. For example, encrypting patient data and using multi-factor authentication can help protect sensitive information. Healthcare organizations should prioritize protecting patient data and complying with regulations like HIPAA (Health Insurance Portability and Accountability Act). Investing in cybersecurity solutions can safeguard patient information and maintain trust in healthcare systems.
How do you see animal testing in the lab, and why, in today’s world, are we still horribly testing on animals? What other alternative way can replace “Testing on Animals in Labs”?
Animal testing is a controversial topic in biomedical research. While it has led to many medical advancements, there is a growing need to find more humane and ethical alternatives. Alternatives to animal testing include using human cells and tissues, computer simulations, organs-on-chips, and advanced imaging techniques. For example, researchers can use human cell cultures to test new drugs instead of animals. Generative AI can simulate biological processes to predict how new drugs will work, reducing the need for animal testing. Investing in these alternative methods can advance science responsibly and ethically.
Finally, tell us about your podcast and who you invite to be your guest to your podcast.
My podcast explores the intersection of healthcare, technology, and innovation. I invite leading experts, entrepreneurs, and thought leaders to discuss the latest trends and developments in healthcare. For example, I might interview a researcher developing a new cancer treatment or an entrepreneur creating a health tech startup. These conversations provide valuable insights and perspectives for our listeners, helping them understand the future of healthcare and its impact on society.
